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ABSTRACT. Biomaterial implantation triggers inflammatory reactions. Understanding the 
effect of physicochemical features of biomaterials on the release of inflammatory cytokines from 
immune cells would be of great interest in view of designing bone graft materials to enhance the 
healing of bone defects. The present work investigated the interactions of two chemically and 
texturally different calcium phosphate (CaPs) substrates with macrophages, one of the main 
innate immune cells, and its further impact on osteogenic differentiation of bone forming cells. 
The behaviour of macrophages seeded on biomimetic calcium deficient hydroxyapatite (CDHA) 
and sintered β-tricalcium phosphate (β-TCP) was assessed in terms of the release of 
inflammatory cytokines and osteoclastogenic factors. The osteogenic differentiation of bone 
progenitor cells (bone marrow stromal cells (BMSCs) and osteoblastic cell line (SaOS-2)) were 
subsequently studied by incubating with the conditioned medium induced by macrophage-CaPs 
interaction in order to reveal the effect of immune cell reaction to CaPs on osteogenic 
differentiation. It was found that the incubation of macrophages with CaPs substrates caused a 
decrease of pro-inflammatory cytokines, more pronounced for β-TCP compared with CDHA 
showing significantly decreased IL-6, TNF-a, and iNOS. However, the macrophage-CDHA 
interaction resulted in a more favourable environment for osteogenic differentiation of 
osteoblasts with more collagen type I production and osteogenic genes (Runx2, BSP) expression, 
suggesting that osteogenic differentiation of bone cells is not only determined by the nature of 
biomaterials, but also significantly influenced by the inflammatory environment generated by the 
interaction of immune cells and biomaterials.
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1. INTRODUCTION
The initial tissue reaction after implantation of a biomaterial is the inflammatory response 
provoked in the host, which largely determines biomaterial’s long-term performance [1–4]. The 
inflammatory host response involves the activation of numerous cell types. Among them, the 
innate immune responses, such as macrophage polarization to either pro-inflammatory M1 or 
anti-inflammatory M2 phenotypes, with the consequent release of a wide range of mediator 
molecules [5,6], will result in different healing pathways. 
In general, as a first step, the implantation of synthetic bone graft leads to the activation of M1 
phenotype, which is coupled with the release of pro-inflammatory cytokines (mainly interleukin 
6, IL-6; interleukin 1, IL-1 and tumour necrosis factor alpha (TNFα)) and reactive species 
intermediates (reactive oxygen species (ROS) and nitric oxide synthase (NOS)). This induces the 
necessary inflammatory phase, resulting in the recruitment of progenitors and immune cells. In 
another hand the chemoattractants and cytokines released in this phase can also stimulate the 
process of osteoclastogenesis [7,8]. Furthermore, prolonged presence of the pro-inflammatory 
M1 phenotype produces chronic inflammation, including the expression of fibrous agents and 
granuloma formation and finally resulting in implant encapsulation and failure [9]. Therefore, the 
effective and timely switch from pro-inflammatory M1 to anti-inflammatory M2 phenotype will 
contribute to active bone tissue regeneration as the secretion of anti-inflammatory cytokines such 
as interleukin 10 (IL-10) is critical in bone forming environment [10] regulating osteogenic 
differentiation of bone cells [11,12]. In general, the functionality of macrophages and thus their 
cytokine release profile is tightly linked to local environmental stimuli. The high plasticity of 
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immune cells has fostered the development of different strategies to control macrophage 
polarization [9]. For instance, the exposure to microbial products such as lipopolysaccharide 
(LPS) activates M1 phenotype and is frequently applied to assess the anti- inflammatory capacity 
of biomaterials [13].
Recently, the possibility to modulate macrophage polarisation by tuning biomaterial properties 
has attracted increasing attention. For instance, it has been shown that the functionality and 
polarization of immune cells can be influenced by chemical [14–19] or topographical [18–22] 
properties of biomaterials. Understanding how the macrophage-biomaterial interaction is 
translated into osteoclastic and osteogenic events would be of great interest in view of designing 
synthetic bone grafts with tailored features to foster bone formation. 
In this context, CaPs are particularly relevant, since they are common bone substitutes due to the 
similarity to inorganic fraction of bone [23-28]. The ionic exchange they promote with the 
extracellular fluids, and more specifically, their ability to locally decrease the concentration of 
calcium and phosphate ions, associated in some instances with the formation of an apatite layer, 
has been proposed to be one of the triggering mechanisms for their intrinsic osteoinductive 
potential [29]. In this context, the effect of CaPs on immune [30,31], osteoclastic [32-36] or bone 
forming cells [37] have been widely investigated. Among the innate immune cells, the 
macrophages were reported to actively participate in the host-cell response to CaPs materials. 
They trigger mesenchymal stem cells (MSCs) migration, making them strong mediators in bone 
formation process [38]. Nevertheless, there is still some knowledge gap regarding the effect of 
the inflammatory environment created after CaPs implantation, on osteoclastogenesis and 
osteogenesis processes. Although recent findings highlighted the role of some physicochemical 
properties of CaPs on modulating osteoimmune responses [39,40], the studies were limited to 
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sintered ceramics such as β-tricalcium phosphate (β-TCP). Recently, biomimetic calcium 
phosphates, which are obtained at low temperature and have structural and compositional 
features much closer to the mineral phase of bone, were shown to have enhanced osteoinductive 
and osteogenic properties [25–27]. Moreover, their structural features can be easily modified 
during synthesis process which allows obtaining biomimetic CaPs with various topographies 
from nano to micro range and triggers specific cell response. For instance, we previously 
demonstrated that bringing the topography of biomimetic calcium deficient hydroxyapatite 
(CDHA) to nanoscale resulted in stimulation of osteogenic activities of bone forming cells whilst 
the increase of porosity of CDHA positively modulated its anti-inflammatory capacity [41]. 
In present work, we aim to study the interplay between the inflammatory environment 
generated by the features of CaPs and the process of osteogenesis. The biomimetic CDHA is 
subjected to a thermal treatment in order to obtain sintered β-TCP ceramic with similar Ca/P 
ratio and porosity but different topography and crystallographic features. In this way we can 
compare the immunomodulatory effects of two CaPs which differ not only chemically but also 
texturally, i.e. plate-like crystals of CDHA vs. polyhedral grains of β-TCP. The inflammatory 
regulation and osteogenic capacity of biomimetic CDHA and a conventional β-TCP ceramic 
were assessed through evaluation of the release of inflammatory, osteoclastogenic factors from 
immune cells, as well as the subsequent effect on bone cell differentiation.
2. MATERIALS AND METHODS
2.1. Material preparation and characterisation 
The synthesis of biomimetic CDHA and β-TCP samples was previously described [42,43]. 
Briefly, CDHA discs were prepared through a cementitious reaction using an α-tricalcium 
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phosphate (α-TCP). The solid phase was a mixture of α-TCP powder and 2 wt.% of precipitated 
hydroxyapatite (PHA; Merck 2143, Merck, Darmstardt, Germany). The solid phase was mixed 
with a liquid phase that consisted of 2.5 wt.% disodium hydrogen phosphate (Na2HPO4; 
Panreac), at a 0.35 mL/g liquid-to-powder ratio (L/P). The paste was placed in Teflon moulds of 
2 mm of height and 6 mm of diameter. The samples were immersed in water at 37 °C for 7 days 
to allow for complete reaction. The β-TCP discs were obtained by sintering the CDHA discs at 
1100 °C for 15 h. 
The microstructure of CDHA and β-TCP was assessed through scanning electron microscopy 
(SEM; TESKAN MIRA3). Prior to visualisation, thin layer of gold was deposited on samples 
using EM SC005 Gold Coater (Leica). To determine the surface roughness of samples, the area 
of 47.5 x 63.4 μm2 was scanned using optical interferometry (Veeco Wyko NT1100) and a 50x 
magnification. Images were acquired using Vision32 software. 
2.2. Cell culture
In current study three models of cells were used: the murine macrophages (RAW 264.7 cells), 
human osteosarcoma (SaOS-2) and human BMSCs. RAW 264.7 and SaOS-2 were expanded in 
Dulbecco’s Modified Eagle Medium (DMEM; Gibco®, Life Technologies Pty Ltd., Australia 
Life Technologies) supplemented with penicillin/streptomycin (50 U/ml and 50 µg/ml, 
respectively), (P/S; Gibco®, Life Technologies Pty Ltd., Australia Life Technologies) and heat-
inactivated foetal calf serum (FCS; In Vitro Technologies, Australia FCS). Cells were maintained 
at 37°C with a 5% CO2 humidified incubator. 
The BMSCs were isolated and cultured following the protocols established in previous reports 
[18,44,45]. Briefly, bone marrow was obtained from 50-60 year old patients undergoing knee or 
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hip replacement. The informed consent was given from all donors and the procedure was 
approved by the Ethics Committee of Queensland University of Technology. The isolation of 
mononuclear cells from bone marrow was performed adding Lymphoprep (Axis-Shield PoC AS, 
Oslo, Norway) following the manufacturer’s instructions. Subsequently, the cells were 
transferred to culture flasks with DMEM with 10% of FCS and penicillin/streptomycin (50 U/ml 
and 50 µg/ml, respectively). Unattached hematopoietic cells were removed via medium changes. 
BMSCs in passage 4-5 were used in the current study. 
2.3. Response of macrophages to CaPs substrates under inflammatory environment
For sterilization, the CaPs samples were immersed in 80% of ethanol. Subsequently, three 
washings with phosphate-buffered saline (PBS, Oxoid) were performed and the discs were then 
left overnight in complete DMEM. Afterwards, the 7x105 RAW cell/cm2 were seeded directly on 
substrates. The anti-inflammatory performance of CaPs substrates was studied by activating the 
M1 proinflammatory phenotype of macrophages with LPS treatment [13,18]. Briefly, the cell 
culture medium was replaced after 12 h with medium containing 1 μg/mL of LPS (LPS, 
Escherichia coli 055:B5, R&D Systems). After 2h of incubation, LPS-containing medium was 
aspirated, samples were rinsed thrice with PBS and transferred to a new well plate. The RAW 
cells on CaPs substrates were then cultured additional 6 hours in serum-fee cell culture medium. 
Subsequently, the CaPs-RAW conditioned medium were recovered for further experiments with 
BMSCs and SaOS-2 cells. Unless otherwise stated, the following experimental procedures were 
applied to LPS-stimulated RAW cells. The macrophage cells cultured on tissue culture 
polystyrene (TCPS) or glass coverslip (CS) and exposed to LPS stimulation are labelled as 
“control+” whilst the RAW cells cultured on TCPS or CS with standard cell culture DMEM 
media are labelled as “control”. 
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2.4. RAW cells morphology
The morphological characteristics of macrophages cultured in direct contact with CaP discs was 
evaluated using SEM (TESKAN MIRA3). Briefly, cells were washed with PBS and fixed with 
3% glutaldehyde at 4oC for 1 h. The process was followed by three risings with PBS and post-
fixation with 1% osmium tetraoxide for 1h. Subsequently, samples were incubated with 
increasing concentrations of ethanol (50%, 70%, 90%, 100%). Complete dehydration was 
achieved adding hexamethyldisilazane (HMDS, Sigma-Aldrich). A thin gold layer was deposited 
on samples using EM SC005 Gold Coater (Leica) and they were visualised by SEM using 5 kV 
of an acceleration voltage.
The morphology of macrophages was additionally visualised using confocal microscopy (CLSM; 
Nikon A1) staining cells for F-actin, nuclei and nitric oxide synthase (iNOS). Cells were washed 
with PBS and fixed with 4% paraformaldehyde (PFA, Sigma-Aldrich) in PBS for 30 min. Then, 
cells were permeabilized with 0.1 % Triton X- 100 (Merck) in PBS for 15 min and blocked with 
1% bovine serum albumin (BSA, Sigma-Aldrich) in PBS for 1h. Cells were then incubated with 
rabbit polyclonal anti-iNOS in 1% BSA (1:100, Abacam) for 1h. Afterwards, cells were 
incubated with Alexa Fluor488 Conjugate anti-rabbit IgG (1:1000, Cell Signaling Technology, 
Danvers, MA) and rhodamine phalloidin in 0.1% Triton X-100 in PBS for 1 h (1:300) in the 
dark. The nuclei were counterstained through 2 min incubation with 4, 6-diamidino-2-
phenylindole (DAPI, Molecular Probes) (1:1000) in 0.1 % Triton X- 100 in PBS. Each step 
during all procedure was followed by 3x washings with 0.15% glycine in PBS. Images were 
treated with Fiji/ImageJ package [46] and cell spreading, iNOS area and cell elongation ratio 
were determined semiquantitatively (n=20). 
  
10
In parallel, RAW morphology on CaPs was also evaluated without LPS activation incubating 
RAW cells with CaPs substrates up to 3 days. Cell morphology was determined at day 1 and 3 
through staining for F-actin and nuclei. Cell number was determined through nuclei counting 
using Fiji/Image-J package. Cell number was compared to control group (RAW seeded on glass 
coverslip) in order to discard cytotoxic effects of CaPs substrates. Moreover, the metabolic 
activity of RAW cells cultured on CaP substrates was evaluated at days 1 and 3 following a 
previously described protocol [41]. 
2.5. Inflammatory and osteoclastogenic behaviour of macrophages 
To evaluate gene expression, cells were lysed and total RNA was obtained using TRIzol reagent 
(AmbionTM, Life Technologies Pty Ltd., AustraliaLife Technologies) following the provider 
protocols at specified cell culture time. The total RNA concentration was determined by 
NanoDrop ND-1000 spectrophotometer (NanoDrop technologies, Motchanin, DE, USA). 
Subsequently, 1000 ng of total RNA were reverse transcribed using DyNAmo™ cDNA 
Synthesis Kit (Genesearch, QLD, Australia). The cDNA template was amplified with the 
Quantstudio TM Real-Time PCR machine (Applied Biosystems, Foster City, California, USA) 
using SYBR Green qPCR Master Mix (Life Technologies). The inflammatory RAW response to 
CaPs was determined analysing the gene expression of pro-inflammatory (IL-1β, IL-6, TNFα, 
iNOS) and anti-inflammatory (IL-10 and CD206) cytokines and surface markers. 
Osteoclastogenic activities of macrophages on CaPs were determined measuring the expression 
CAR2, CTSK and MMP9. The sequences of primers are listed in Table 1. The specificity of 
primers was determined by analysis of melt curves. The mean cycle threshold (Ct) value of each 
target gene was normalized against the Ct value of the endogenous control 18S. In order to 
compare the effect of two different chemistries of CaPs, the using comparative Ct (2−ΔΔCT) 
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method was applied where ΔΔCt= (Ctsample (gene of interest) - Ctsample (endogenous reference 
gene)) – (CtTCPS (gene of interest) – CtTCPS (housekeeping gene)) [47]. Control+ was used as a 
calibrator sample. 









































































Collagen type I COLL I
F:AGAACAGCGTGGCCT
R:TCCGGTGTGACTCGT
Moreover, the cytokine release was analysed using enzyme-linked immunosorbent assay 
(ELISA). Specifically, the presence of IL-6, TNF-α and IL-10 was evaluated using a mouse IL-6 
Uncoated ELISA kit, a mouse TNF-α Uncoated ELISA kit and a mouse IL-10 Uncoated ELISA 
kit respectively (all from Invitrogen). 
2.6. Measurement of ion concentration of cell culture medium
The concentration of Ca2+ and Pi, with and without presence of RAW cells on CaPs, was 
evaluated in the medium using inductively coupled plasma-optical emission spectrometry (ICP-
OES, Perkin Elmer, MA, USA). Prior to analysis, the sample supernatants were diluted fivefold 
with 2% of ultrapure nitric acid (Sigma-Aldrich). 
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2.7. The effect of CaPs- RAW conditioned media on osteogenesis
The effect of the microenvironment created by the immune cells cultured on CaP substrates on 
osteogenesis was determined by incubating bone-forming cells with CaPs-RAW conditioned 
extracts. Briefly, BMSCs and SaOS-2 cells were separately seeded on tissue culture plastic 
(TCPS) at densities of 1x104 cells/cm2 and 2.5x104 cells/cm2, respectively. After 12h of 
adhesion, the CaPs-RAW extract previously supplemented with 10% of FCS was added. The 
BMSCs and SaOS-2 cells were exposed to CAPs-RAW extracts up to three days without 
medium change. Additionally, the SaOS-2 cells were also seeded on the CaPs discs and exposed 
to CaPs-RAW conditioned or CaP- conditioned extracts. Afterwards, the expression of 
osteogenesis-related genes (ALP, Runx2, COLL I, BSP, BMP-2 and OCN) was determined 
following the protocol described in section 2.5. The values of gene expression were normalised 
to 18S as a housekeeping gene and BMSCs+ and SaOS-2+ groups were used as a calibrator 
samples. Over following manuscript “BMSCs+” and “SaOS-2+” refers to respectively 
mesenchymal and osteoblastic cells exposed to extracts from LPS-stimulated RAW cells. 
Additionally, for SaOS-2 cells, the protein expression was determined through CLSM 
visualisation (for ALP) and western blot (for ALP, COLL I and Runx2). For CLSM analysis the 
cells were placed on glass coverslip. Afterwards, standard fixation and staining protocol for 
CLSM visualisation were applied (section 2.4.). The rabbit anti-human ALP (1:100, Abacam) 
and Alexa Fluor488 Conjugate anti-rabbit IgG secondary antibody (1:1000, Cell Signaling 
Technology, Danvers, MA) were used as a primary and secondary antibody, respectively. Images 
were treated using Fiji/ImageJ package. The cell spreading and elongation ratio as well as the 
ALP area were determined semiquantitely (n=20) using the same software. 
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For western blot analysis, cells were lysed with RIPA buffer and total protein was quantified by 
Pierce™ BCA Protein Assay Kit (Thermo Fisher Scientific). The sodium dodecyl sulfate–
polyacrylamide gel electrophoresis (SDS-PAGE) were used to separate 20 μg of proteins. 
Subsequently, they weretransferred onto a nitrocellulose membrane (Pall Corporation, East Hills, 
New York, USA) and blocked with Odyssey blocking buffer (LI-COR Biosciences, Lincoln, 
Nebraska, USA) for 1h. The membrane was incubated overnight at 4oC with antibodies against 
ALP, Runx2, COLL I or α-tubulin (all 1:1000, rabbit anti-human; Abcam, Cambridge, United 
Kingdom) followed by incubation with anti-mouse/rabbit IRDye 700/800 conjugated antibody 
(1:5000, Rockland, Gilbertsville, Pennsylvania, USA). In order to remove non-specific binding, 
washes with TBS-Tween buffer were performed between each incubation step. The Odyssey 
infrared imaging system (LI-COR Biosciences, Lincoln, Nebraska, USA) was used to visualise 
the bands. The intensity of bands was determined through Fiji/ImageJ package. 
To quantify mineralization, the semi-confluent 3x104 BMSCs/cm2 BMSCs and 6x104 SaOS-2 
/cm2cells were seeded on TCPS. After 24h, the solution ofCaPs-RAW extracts and DMEM with 
osteogenic supplements: 50 µg/mL ascorbic acid, 10 mM β-glycerophosphate and 100 nM 
dexamethasone was added. The medium was replaced every third day. At day 14, the cells were 
thoroughly rinsed with double distilled H2O (ddH2O) and the fixation was performed incubating 
cells for 15 min at room temperature with 4% PFA. Subsequently, the Alizarin red solution 
(ARS, Sigma-Aldrich) at pH 4.2 was added and the cells were incubated for 20 min. The 
unbound stain was eliminated through several rinses with ddH2O. The samples were air-dried, 
and the images were acquired using a light microscope (Nikon ECLIPSE TS100).
2.8. Statistical analysis 
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The statistical analysis was performed using SPSS software (IBM SPSS, Armonk, NewYork, 
USA). The data was plotted as mean ± standard deviation (SD). The normality was checked 
through the Saphiro–Wilk test. In case of significance of Saphiro-Wilk test, the statistical 
differences between groups was determined by Mann-Whitney U test. In case of non-significant 
Saphiro-Wilk test, the statistical differences between groups was determined by T-Student test. 
For all tests, the level of significance was set for p< 0.05. 
3. RESULTS
3.1. Physicochemical characterisation of CaPs
SEM micrographs showed that the microstructure of biomimetic CDHA was formed of 
aggregates with plate- like crystals and average roughness (Ra) of 2.5 ± 0.72 μm. The sintering 
process applied to β-TCP led to coalescence of crystals within CDHA aggregates, resulting in 
polyhedral grain microstructure (Figure 1) and lower Ra being 1.33 ± 0.23 μm. Further 
characterisation regarding substrates’ SSA and porosity was described in a previous work [48–
50] and displayed in Figure 1C. 
  
16
Figure 1. A) Representative SEM micrographs of CDHA and β-TCP surface morphology. B) 
Optical interferometry images of surface topography of CDHA and β-TCP substrates. C) 
Physicochemical properties of substrates used in the study [49,51]. 
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3.2. No cytotoxic effect of CaP substrates on the macrophage cell line (RAW cells) 
Macrophages adhered at similar numbers on CaP substrates and control. A progressive increase 
of cell number was observed from day 1 to day 3 of cell culture. β- TCP presented statistically 
significant higher number of RAW cells at day 3 compared to control (Figure 2A). Moreover, an 
increase of metabolic activity of macrophages from day 1 to day 3 was observed in all CaPs. 
Both substrates presented similar values compared to the control group (Figure 2B).
In general, RAW cells cultured on CaPs and control presented a round-shaped morphology 




Figure 2. A) The number of attached RAW cells to CaP substrates. The quantification was based 
on nuclei counting of CLSM images acquired at day 1 and day 3 of cell culture. B) Metabolic 
activity of RAW cells on CaPs substrates detected by MTT. In A) and B) & indicates statistically 
significant difference (p<0.05) compared to control. No statistically significant difference 
(p<0.05) was observed between CDHA and β-TCP substrate. C) CLMS images of macrophages 
on CaP discs at day 1 and 3 of cell culture. The F-actin (red) and cell nuclei (blue) were stained. 
The brightness and contrast of images were adjusted using Fiji/Image-J package. D) 
Representative SEM images of morphology of RAW on CaPs at day 1 and 3 of cell culture. In 
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A), B) and C) “Control” refers to RAW seeded on glass coverslip while in D) “Control” refers to 
RAW seeded on TCPS.
3.3. CaP substrates could down-regulate the inflammatory response of macrophages 
under inflammatory conditions 
Inflammatory conditions were induced through incubation of RAW cells with LPS. 
Subsequently, the gene expression and cytokine release of macrophages cultured on CaPs was 
evaluated in terms of inflammatory, osteoclastic and osteogenic activities.
3.3.1. The inflammatory response of RAW cells cultured on CaPs
The gene expression of pro-inflammatory (IL-1β, IL-6, TNFα and iNOS) and anti-inflammatory 
(IL-10 and CD206) genes and surface markers are depicted in Figure 4A. In general, the 
culturing of macrophages on CaPs discs resulted in a downregulation of pro-inflammatory genes 
compared to control group. These values were approximately 4-fold (for IL-1β and IL-6) and 2-
fold (for TNF-α and iNOS) lower compared to control. Moreover, the downregulation of pro-
inflammatory molecules was significantly more pronounced on β-TCP than on biomimetic 
CDHA. No statistically significant differences were observed for the expression of anti-
inflammatory cytokine IL-10. However, CaP substrates downregulated the expression of surface 
marker CD206, more markedly in the case of β-TCP (Figure 3A). Moreover, both substrates 
decreased the release of pro-inflammatory IL-6 and TNFα being this scenario more pronounced 
for β-TCP (Figure 3B).
The anti-inflammatory capacity of CaPs was also assessed through iNOS visualisation (Figure 
3C). The presence of iNOS-positively stained RAW cells was observed in both CaP substrates. 
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Nonetheless, β-TCP showed lower iNOS- stained area compared to CDHA and control+ group 
(Figure 4D, middle graph). 
Figure 3. The response of RAW cells to CaP substrates under inflammatory environment (6 
hours after LPS stimulation). A) Relative expression of pro-inflammatory (left) and anti-
inflammatory (right) genes of macrophages cultured on CaP samples. The values were 
normalised to 18S as a housekeeping gene and using LPS-stimulated macrophages (control+) as 
a calibrator. The dashed line indicates the relative fold equal to 1. * indicates statistically 
significant difference (p<0.05) of β-TCP substrate compared to CDHA. B) Levels of M1 pro-
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inflammatory (IL-6 and TNFα) cytokines in cell culture media supernatants. The M2 anti-
inflammatory (IL-10) cytokine was not detected [41]. C) Representative CLSM images of iNOS- 
positively stained RAW cells on CaPs. The F-actin (red), cellular nuclei (blue) and iNOS (green) 
were stained. The brightness and contrast of images were adjusted with Fiji/ImageJ package. D) 
Semiquantitative analysis of RAW spreading, iNOS occupied area and elongation ratio. Symbols 
represent individual cells (n=20), the boxes represent 25th and 75th percentile, the middle line is 
the median, the □ is the mean and whiskers are standard deviation. & indicates statistically 
significant difference (p<0.05) compared to control+. * indicates statistically significant 
difference (p<0.05) of β-TCP substrate compared to CDHA.
The elongation ratio and spreading area of cells cultured on CaPs substrates provides an 
indication of the polarization of macrophages to either pro or anti-inflammatory phenotype 
(Figure 3C and Figure 4) [52]. RAW cells cultured directly on CaP substrates presented lower 
spreading area than the control, this being more pronounced for macrophages cultured on CDHA 
(Figure 3C, top graph). However, similar cell elongation ratios were observed for both substrates 
(Figure 3C, bottom graph). The cell morphologies observed by SEM were compatible with on β-
TCP and CDHA surfaces (Figure 4). 
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Figure 4. SEM micrographs of morphology of on CaP substrates cultured under inflammatory 
environment (6 hours after LPS stimulation). Pseudo coloured blue and orange cells indicate 
macrophages with pancake-like and elongated morphology (i.e. M1 and M2-like cell shape), 
respectively. White arrows show putative direction of spreading of macrophages. 
3.3.2. Regulation of osteoclastic-like behaviour of RAW cells by CaPs
The culture of RAW cells on CaP substrates resulted in the downregulation of osteoclastic 
marker genes (CTSK, CAR2 and MMP9) (Figure 5A). Similar decrease in the expression of 
CTSK and CAR2 genes was observed for both CDHA and β-TCP, whist the downregulation of 
MMP9 was more pronounced for β-TCP. 
The levels of calcium and phosphate were monitored in presence or absence of cells (Figure 5B). 
The concentration of Ca2+ and Pi in the pristine DMEM were 1.66 ± 0.00 mM and 1.09 ± 0.02 
mM, respectively. The immersion of CDHA in the DMEM caused a 17.19 ± 2.60% decrease of 
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Ca2+ concentration, which was counteracted by a slight increase in presence of the RAW cells 
(Figure 5B, left graph). No alteration in Ca2+ concentration was noted for β-TCP. On the other 
hand, little alterations of phosphate were observed (Figure 5B, right graph) in any of the culture 
conditions. 
The resorptive behaviour of macrophages on CaPs was additionally evaluated through SEM 
imaging of the cell-material interphase (Figure 5C, left graph). The morphology of the CaP 
substrate areas adjacent to the RAW cells was similar to the pristine substrate, with no signs of 
degraded crystals. Few multinucleated cells, which could be associated to a resorptive activity, 
were found on both CDHA and β-TCP (Figure 5C, right graph).
Figure 5. Osteoclastic-like behaviour of RAW on CaPs after 6 hours of LPS- stimulation. A) 
Relative expression of osteoclastogenesis-related genes (CTSK, CAR2 and MMP9) of RAW. 
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The values were normalised to 18S as a housekeeping gene and using RAW cells after 6 hours of 
LPS-stimulation (control+) as a calibrator sample. The dashed line indicates the relative fold 
equal to 1. B) Ionic alterations of calcium and phosphate cause by CaP substrates in absence and 
presence of macrophages. In A) and B) & and * indicate statistically significant difference 
(p<0.05) compared to control and CDHA, respectively. In B) # indicates statistically significant 
difference (p<0.05) between ionic concentration of cell culture medium with or without cells. C) 
Representative SEM and CLSM images of CaPs-RAW interphase (left) and multinucleated 
macrophages (right). The F-actin (red) and cellular nuclei (blue) were stained. The brightness 
and contrast of CLSM images were adjusted with Fiji/ImageJ package.
3.4. The impact of osteoimmune environment of RAW cells-CaP interaction on 
osteogenesis
The ability of macrophages cultured on CaP substrates to stimulate osteogenesis was analysed 
using RAW-CaPs extracts and assessing the capacity of the macrophage-secreted molecules to 
induce the osteogenic differentiation of BMSCs and SaOS-2. 
Stimulation of BMSCs with RAW-β-TCP conditioned medium produced a significant 
downregulation on the gene expression of osteogenesis-related markers (Runx2, ALP, COLL I, 
BSP, OCN and BMP-2) compared to cells cultured with RAW-CDHA extracts (Figure 6A, top 
graph). The incubation with RAW-CDHA extracts resulted in upregulation of Runx2 and BSP 
compared to that in BMSCs+ group. No significant impact on mineralization was observed 
showing similar ability of BMSCs to generate calcium deposits and nodule formation, 
irrespective of the RAW-CaP extract stimulation (Figure 6B). 
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Figure 6. The impact of osteoimmune environment on osteogenesis. A) The effect of CaPs-
RAW extracts on osteogenic gene expression of BMSCs (top) and SaOS-2 (bottom), 
respectively. The values of gene expression were normalised to 18S as a housekeeping gene and 
corresponding BMSCs+ and SaOS-2+ groups were used as a calibrator sample. The dashed line 
indicates the relative fold equal to 1. * and & indicate statistically significant difference (p<0.05) 
compared to CDHA and corresponding control group (either BMSCs+ or SaOS-2+), 
respectively. The “BMSCs+” and “SaOS-2+” indicates cells incubated with extracts from LPS-
stimulated RAW cells. B) The effect of CaPs-RAW conditioned medium on mineralization of 
BMSCs (left) and SaOS-2 (right).  
Compared with the primary cells (BMSCs), SaOS-2 cells showed to be less prone to extract 
stimulation compared to BMSCs. Incubation with RAW-β-TCP extract resulted in an increase of 
Runx2 gene expression and a decrease of BSP, OCN and ALP levels, being statistically 
significant only for ALP (Figure 6B, bottom). Noteworthy, expression of BMP-2 was not 
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detected for SaOS-2 cells. In general, little upregulation of osteogenic markers was observed for 
RAW-CaP extracts compared to SaOS-2+. Moreover, ostoblastic cells presented a more 
intensive staining with Alizarin Red suggesting higher deposition of calcium and formation of 
nodule compared to BMSCs (Figure 6B). No differences in terms of mineralization were 
detected for ostoblastic cells incubated with either RAW-β-TCP or RAW-CDHA extract. For the 
condition where SaOS-2 were cultured directly on the CaPs discs, the CaP-RAW-extracts 
downregulated some of early osteogenic markers (ALP, BSP). Instead, the late osteogenic 
marker (OCN) was upregulated by incubation with both CaP- and CaP-RAW conditioned 
medium (Figure S2). 
In general, the effect of RAW-CaP extracts on the ostoegenesis of SaOS-2 cells was more 
pronounced in protein (Runx2, ALP and COLL I) content evaluated through western blot (Figure 
7C and D). Overall, the production of the three measured proteins was significantly higher in 
SaOS-2 cells stimulated with RAW-CaP conditioned medium compared to cells incubated with 
extracts from LPS-stimulated RAW cells (SaOS-2+) (Figure 7D). Moreover, the secretion of 
COLL I by SaOS-2 cells was more pronounced after incubation with RAW-CDHA extracts. 
Additionally, the ALP protein expression was visualised using CLSM technique (Figure 7A). 
The cell spreading area was higher in SaOS-2 cells cultured with RAW-CDHA extract compared 
to SaOS-2+ group (Figure 7B, left graph). No impact of RAW-CaP conditioned medium on 
SaOS-2 elongation ratio was observed (Figure 7B, right graph). 
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Figure 7. The effect of CaPs-RAW - extracts on protein expression and morphology of SaOs-2 
cells. A) Representative CLMS images of SaOS-2 after 3 day exposure to CaPs-RAW extracts. 
The F-actin (red), cellular nuclei (blue) and ALP (green) were stained. The brightness and 
contrast of images was adjusted with Fiji/Image-J package. B) Semiquantitative analysis of 
SaOs-2 spreading, ALP occupied area and elongation ratio. Symbols represent individual cells 
(n=20), the boxes represent 25th and 75th percentile, the middle line is the median, the □ is the 
mean and whiskers are standard deviation. * indicates statistically significant difference (p<0.05) 
compared to SaOS-2+. No significant differences were observed between substrates. C) The 
Western blot of proteins related to osteogenesis (COLL I, Runx2, ALP) detected by Western blot 
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D) Corresponding relative intensity of Western Blot bands. & indicates statistically significant 
difference (p<0.05) compared to control+. * indicates statistically significant difference (p<0.05) 
compared to CDHA. In all figures, “SaOS-2 +” represents cells incubated with extracts from 
LPS stimulated RAW cells.
4. DISCUSSION 
The capacity of biomaterials to modulate macrophage polarisation has been object of different 
studies [2,16,18,20–22,53–55]. In the field of synthetic bone grafts this is especially relevant, 
since tunning the inflammatory response may allow fostering the osteogenic properties of these 
materials. The present work addressed the interactions of two different bone substitutes, namely 
β-TCP and CDHA with immune cells. Although the elemental composition of these two 
compounds is identical, both having a Ca/P ratio of 1.5, the different synthetic routes followed in 
each case, i.e. biomimetic precipitation for CDHA and high-temperature sintering for β-TCP, 
result in different crystal structure, surface topography, roughness and specific surface area 
(Figure 1) [50].  The RAW 246.7 cell line was used as a model to study CaPs influence on 
immune cells response. The analysis of cell number revealed that both CaPs supported adhesion 
and proliferation of macrophages (Figure 2), in agreement with previous studies [56]. This is 
particularly important as the accumulation of macrophages at early stage of inflammation is a 
contributing factor to wound repair [57]. Although CDHA caused a decrease of Ca2+ 
concentration in the cell culture medium, associated to the maturation of the apatitic phase, as 
reported previously for this type of material [54], the small sample size mitigated the extent of 
the ionic fluctuations, reducing the impact in cell proliferation [48,50,59,60]. In this respect, it is 
important to highlight that the maturation of CDHA, which involves the evolution from its 
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calcium-deficient nature to a more stoichiometric form is a long-term process that occurs 
progressively when the biomimetic substrate is exposed to cell culture medium [48]. Therefore, 
no significant changes in the substrate composition are expected in the short cell culture times 
analysed in this study. Although immune cells have been reported to be sensitive to the textural 
features of the substrate, previous studies showed that the impact was rather in the phenotypic 
switch [3,61] and cytokine release [18,19,62] than in cell proliferation. 
In order to assess the anti-inflammatory capacity of CaPs, macrophages were firstly stimulated 
with LPS. This molecule of bacterial origin activates pro-inflammatory M1 phenotype [63] and 
cytokine release [64] and is commonly used in inflammation related studies [65]. The induction 
of the pro-inflammatory state was confirmed by the presence of iNOS-positively stained cells for 
both CaP substrates (Figure 3B). Interestingly, the cells cultured on β-TCP exhibited a 
significantly higher reduction of iNOS area (Figure 3C, middle graph). Moreover, although both 
biomimetic CDHA and sintered β-TCP significantly downregulated the gene expression and 
release of pro-inflammatory cytokines compared to LPS-stimulated RAW cells (control+) 
(Figure 3A and 3B), the reduction was more pronounced for β-TCP in four out of the six 
analysed genes involved in the inflammatory process. We hypothesize that the enhanced 
suppression of pro-inflammatory state by β-TCP is likely due to reduced levels of iNOS. For 
instance, Chamberlain et al. suggested a close relation between the reduction of local pro-
inflammatory response and low levels of nitric oxides [66]. Nevertheless, one should remember 
that the immunomodulatory effects of the substrates also depends strongly on the condition to 
which immune cells are exposed. Thus, the expression of inflammatory cytokines vary either if 
the cells are stimulated with LPS (Figure 3A) or cultured under non-inflammatory environment 
(Figure S1) [41].The inflammatory activation of macrophages is normally associated to 
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morphological changes [63]. Whereas the anti-inflammatory M2 phenotype is usually 
characterised by a more elongated aspect [9,52]. Pro-inflammatory macrophages exhibit 
rounded-like shapes accompanied with an enlargement of the spreading area [9,67] The SEM 
images revealed an heterogeneous profile of the macrophages cultured on CDHA and β-TCP, 
with presence of both M1-like and M2-like morphological features (Figure 4). Although no 
significant differences were found in terms of the elongation ratio (Figure 3C, bottom graph), 
RAW cells presented smaller spreading areas on the CaP substrates compared to control+ 
(Figure 3C, upper graph), which can be related to the downregulation of pro-inflammatory 
cytokines by CaPs (Figure 3A). 
Beyond the immune reaction, the macrophages are known to control osteogenesis and 
osteoclastogenesis through the release of a wide range of molecules. For instance, several studies 
underlined the importance of macrophages population for induction of the MSC-based bone 
regeneration. Specifically, an increased mobilization of immune cells was observed on CaP 
substrates with transplanted MSCs prior to MSC-mediated ectopic bone formation [68,69]. 
Moreover, macrophages, as osteoclast precursor cells, can exhibit some osteoclastic-like activity, 
such as the expression of osteoclastic enzymes, or the capacity to resorb CaP substrates [39]. 
Although previous studies reported a stimulatory effect of CDHA chemistry and topography 
osteoclastic differentiation [35,39], we observed little osteoclastic actions of RAW cells in 
contact with CDHA or with β-TCP. For instance, no actin rings were observed in the 
multinucleated RAW cells (Figure 5C, right graph), a morphological feature of osteoblastic-like 
cells through which they create sealed regions that can be subjected to acidic resorption [70], 
Likewise, no signs of degradation were found in the CaP substrates (Figure 5C, left graph), the 
microstructure of the substrate remaining intact in the cell-biomaterial interphases. There was no 
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evidence either of ionic alterations, like an increase of calcium concentration in the cell culture 
medium, which might have been the result of the resorptive activity of cells (Figure 5B) [35,39]. 
Moreover, little differences were observed in the expression of osteoclastogenic molecules 
(CTSK, CAR2 and MMP9) (Figure 5A). Even though osteoclastic response of macrophages to 
bone grafts can be observed at short time of cell culture [33,39], we hypothesize that the 
incubation of RAW cells with the CaP substrates without any additional stimulation prevented 
them from revealing their putative osteoclastic nature. Indeed, the RAW cells do not represent 
fully functional osteoclastic cells [71]. The full differentiation of monocytes/macrophages to 
osteoclasts, and hence specific osteoclastic behaviour can be only triggered through contact with 
stimuli such as OPG, RANKL, and M-CSF [72]. 
The crosstalk between immune cells and the bone forming cells is essential to complete the 
inflammation stage and to initiate the new bone formation. Here, we studied the simultaneous 
effect of secreted molecules from RAW cells cultured on CaPs and the ionic environment 
produced by the interaction of the CaP substrates with the cell culture medium, on the osteogenic 
differentiation of mesenchymal and osteoblastic cells (Figure 6 and 7). The exposure of BMSCs 
to CDHA-RAW conditioned medium resulted in higher values of Runx2 and BSP (Figure 6). 
This result is particularly interesting inasmuch as CDHA activated in more pronounced manner 
the expression of pro-inflammatory cytokines by macrophages compared to β-TCP (Figure 3A), 
which would be expected to result in attenuated osteogenic gene expression by bone forming 
cells [73,74]. However, some studies have underlined that the proper combination of pro-
inflammatory molecules, e.g. IL-1β and TNFα, might also lead to enhanced osteogenic 
differentiation as well as formation of calcium deposits and nodules [12,75,76]. Another 
interesting fact is that RAW cultured on CDHA simultaneously expressed higher levels of anti-
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inflammatory IL-10 and CD206 compared to β-TCP, which was previously associated with M2b 
macrophages-a subtype of anti-inflammatory immune cells [77]. Unlike Chen et al. we did not 
notice enhanced osteogenesis of BMSCs after incubation with β-TCP-RAW conditioned medium 
[78]. We hypothesize that this should be likely associated with different form of β-TCP (powder 
vs bulk material) and subsequent different interaction with cell culture medium and immune 
cells. In our previous work we demonstrated that incubation of MSCs with extracts from bulk 
CaPs, and thus exposing them to CDHA-conditioned environment, was not sufficient stimulus to 
induce differentiation of MSCs into osteoblastic lineage [50]. Therefore, we hypothesize 
enhanced osteogenic differentiation of BMSCs observed in current study should be associated 
with the release of osteogenic and inflammatory stimuli from macrophages cultured on CDHA 
substrates rather than with the microenvironment created by bulk CaPs after immersion in cell 
culture medium. 
Finally, we assessed the effect of RAW-CaPs osteoimmune environment on more reliable 
osteoblast cell line i.e. SaOS-2. In general, osteoblastic gene expression of SaOS-2 was not 
significantly affected when exposed to the RAW cells supernatants, except in the case of 
downregulation ALP for the β-TCP-RAW extract compared to CDHA-RAW extract (Figure 
6A). This is in agreement with previous findings that demonstrated that SaOS-2 cells are less 
prone to the microenvironmental changes compared to mesenchymal stem cells [50, 79]. CLMS 
image semiquantitative analysis showed enhanced cell spreading [80] after exposure to RAW-
CDHA supernatants, what might suggest greater capacity of microenvironment created by this 
substrate to induce osteogenic differentiation (Figure 7A and B) [80]. Moreover, the effect of 
osteoimmune environment was reflected in protein expression (Runx2, COLL I and ALP) 
(Figures 7C and D). The results agree with those obtained for BMSCs, showing that more 
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favourable environment for osteogenesis is obtained when immune cells are cultured on 
biomimetic CDHA. Overall, a stimulatory effect was observed when osteoblastic cells were 
cultured with extracts from macrophage’s cultured on CaPs (Figure 6 and 7), a phenomenon 
previously observed [78]. We initially studied this condition to analyse the effect of macrophages 
on osteoblastic differentiation without considering the stimulatory effect of CaPs [48,50]. 
Interestingly, when osteoblastic cells were cultured directly on the CaPs and with extracts from 
activated macrophages (Figure S2), osteoblastic cells differentiated earlier suggesting a 
synergistic effect of CaP and cytokines released from macrophages. Nonetheless, better 
comprehending of this relation requires further in vitro investigation of signalling pathways 
responsible for enhanced osteogenic differentiation of bone forming cells. Therefore, further in 
vivo testing designed to study the interaction between immune and bone cells should be 
performed to fully support driven hypothesis.
5. CONCLUSIONS 
In general, sintered β- TCP reduced to greater extent the release of inflammatory cytokines 
compared to biomimetic CDHA. Nonetheless, the microenvironment created after culturing 
macrophages on CDHA showed more potent osteogenic effects, fostering osteogenic 
differentiation of both BMSC and SaOS-2 cells. Overall, the results from the present work 
demonstrated that calcium phosphates with different chemical and textural properties modulate 
differently the immune cell response. This opens the door to new strategies to design smart cell-
instructive biomaterials that adapt their performance during all stages of bone healing process 
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Statement of significance 
The field of osteoimmunology highlights the importance of the cross-talk between immune and 
bone cells for effective bone regeneration. This tight interaction opens the door to new strategies 
that encompass the development of smart cell-instructive biomaterials which performance covers 
the events from early inflammation to osteogenesis. The present work links the anti-
inflammatory and osteoimmunomodulatory features of synthetic bone grafts to their chemistry 
and texture, focussing on the cross-talk between macrophages and two major orchestrators of 
bone healing, namely primary mesenchymal stem cells and osteoblasts. The results emphasize 
the importance of the microenvironment created through the interaction between the substrate 
and the immune cells as it can stimulate osteogenic events and subsequently foster bone healing.  
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